Marking another significant milestone in its growth strategy, Reformulary Group is proud to announce its new partnership with Johnston Group, a leading Canadian benefits provider

Johnston Group chooses Reformulary to meet clients’ needs for savings and innovation in a sustainable value-driven drug plan

Toronto, November 29, 2021. Reformulary announces today a new and exciting partnership with Johnston Group, who will offer the Reformulary to its Maximum Benefit clients across Canada. Johnston Group joins Reformulary’s roster of five plan administrators offering the Reformulary to their clients. To-date, over 1,000 organizations including companies, associations, and unions serving over a quarter million Canadians subscribe to the Reformulary.

“This is a milestone moment for Reformulary,” said Helen Stevenson, CEO of Reformulary. “More and more Canadian business are signing on to Reformulary, because of the value we provide through savings, seamless member experience and plan sustainability; we are changing the drug plan landscape in Canada. And we’re extremely proud to partner with Johnston Group.”

Reformulary helps Canadians with benefit plans navigate prescriptions to make smart drug choices. Through expert advice offered by world-renowned clinicians, data analyses, and an innovative tool called Reformulary DrugFinder®, members can make sense of medicine and find the prescription that is preferred on the Reformulary.

“Johnston Group is committed to listening to our customers and offering leading solutions.” said Gerri O’Leary, Vice-President, Maximum Benefit, Johnston Group. “We are partnering with Reformulary Group because their managed formulary, the Reformulary, and DrugFinder tool deliver the value our customers are looking for as well as evidence-based solutions, sustainability, innovation and choice.”

Reformulary Group has invested more than 200,000 hours of time reviewing the evidence for drugs, with the input of an independent panel of medical experts. The Reformulary provides a smarter formulary for employees, at a better cost for employers. We also have access to billions of data points, which provide unique insights into the real-world use of prescription drugs. ‘Powered by Reformulary’ has become the sign of quality and innovation.


About Reformulary

Founded in 2011, Reformulary Group is an expert-led healthcare company focused on helping Canadians make sense of medicine. The company’s proprietary drug list, the Reformulary®, and award-winning DrugFinder™ digital tool provide Canadians with valuable comparative drug information, reviewed and vetted by an independent committee of doctors and pharmacists from across Canada. Reformulary Group built Cannabis Standard™, a discovery tool to guide medical cannabis use. Cannabis Standard also enables patients to search and compare products and to track the impact of medical cannabis on their quality of life using a survey tool recognized by healthcare professionals worldwide.

For more information visit

About Johnston Group

Johnston Group has been a full-service Third-Party Administrator and Payer for nearly 40 years. They provide employee benefit solutions to 30,000 Canadian businesses and 250,000 plan members through several programs. Johnston Group administers Chambers of Commerce Group Insurance Plan®, Canada’s #1 group benefit plan for small businesses. In addition, Johnston Group administers Maximum Benefit for larger companies, offering self-funded health, dental, and STD benefits with access to the open market for the insured portion of the plan. Johnston Group also administers CINUP, which provides a specialized employee benefits program to First Nations and Inuit organizations. Johnston Group is headquartered in Winnipeg and believes strongly in giving back by contributing to local health, arts, sports, and other community organizations. They are also proud to be recognized as a Platinum Member of Canada’s Best Managed Companies, Manitoba’s Top Employers (2021), and Canada’s Top Small and Medium Employer’s (2021).

For more information, visit

Media Contact

Lyn Whitham